Filing Flows › Innoviva (INVA) › Capital expenditures
Innoviva (INVA) capital expenditures by quarter
Innoviva's capital expenditures were $24K in Q3 2026 (third quarter 2026), -94% from Q2 2026. Over the last 5 quarters it ranged from $10K (Q4 2025) to $1.1M (Q3 2025).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $24K | -94% | -98% |
| Q2 2026 | $429K | -13% | — |
| Q1 2026 | $492K | 49× | — |
| Q4 2025 | $10K | -99% | — |
| Q3 2025 | $1.1M | — | — |
Q3 2026 at a glance
Innoviva, Q3 2026: revenue $106M (-2% year over year), operating margin 39.7%, net loss $73.9M, operating cash flow $41.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is Innoviva's capital expenditures?
Innoviva's capital expenditures were $24K in Q3 2026 (third quarter 2026), -94% from Q2 2026.
How has Innoviva's capital expenditures changed?
Over the last 5 quarters it ranged from $10K (Q4 2025) to $1.1M (Q3 2025).